Detalhe da pesquisa
1.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237172
2.
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Gynecol Oncol
; 178: 161-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890345
3.
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes.
Cell Chem Biol
; 26(11): 1559-1572.e9, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543462
4.
Deficits in learning and memory in mice with a mutation of the candidate dyslexia susceptibility gene Dyx1c1.
Brain Lang
; 172: 30-38, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25989970
5.
DYX1C1 is required for axonemal dynein assembly and ciliary motility.
Nat Genet
; 45(9): 995-1003, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23872636
6.
DYX1C1 placed in a molecular context.
Biol Psychiatry
; 73(6): 497-8, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23438632